E-DRUG: UNITAID Symposium- TB treatment lessons learnt, issues, future opportunities
----------------------------------------------------------------------------
[Please contact: Jia Si Duan at <duanj@who.int> if you are interested. DO NOT CLICK REPLY.]
UNITAID Symposium
42nd Union World Conference on Lung Health
Market-based approaches in TB treatment scale-up: lessons learnt,
remaining issues, and future opportunities
Saturday 29 October 2011
14:30 - 16:30
Lille Grand Palais, Room Jeanne de Flandre 2
There are finally TB products in the pipeline that have the potential
to revolutionize diagnosis and care. However, unless the global health
community works together to address significant shortcomings in the TB
market, the true potential of these new and innovative technologies
will not be realized. This symposium provides an overview of market
challenges in TB, highlights the need for new partnership models to
address these challenges, reviews lessons learnt from UNITAID
partnerships, and explores innovative approaches to address the
shifting TB market landscapes of the future.
Chair
Carol Nawina Nyirenda
Community Initiative for TB, HIV/AIDS & Malaria (Zambia)
Presenters
Brenda Waning, UNITAID
Shrikant Kulkarni, Lupin
Tahir Amin, Initiative for Medicines, Access & Knowledge (I-MAK)
Lisa Hedman, World Health Organization, Essential Medicines and
Pharmaceutical Policies
Anban Pillay, National Department of Health, South Africa
Philippe Duneton, UNITAID
Cocktail reception to follow
For registered Union Lung Conference participants interested in
attending this symposium,
please contact: Jia Si Duan at duanj@who.int
"Blumer, Katherine" <blumerk@who.int>